FDA Warning Letter — Avara Liscate Pharmaceutical Services SPA

Case 439066 — FEI 3004640070

The FDA took a Warning Letter action against Avara Liscate Pharmaceutical Services SPA on Mar 31, 2015 (Liscate, Italy). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Avara Liscate Pharmaceutical Services SPA
Date
Mar 31, 2015
Fiscal Year
2015
Product Type
Drugs
Center
CDER
Location
Liscate (Italy)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.